Christoph Huber

Serum levels of cytokines in chronic liver diseases

Herbert Tilg, Axel Wilmer, Wolfgang Vogel et al. · Gastroenterology · 1992 · 747 citations · Full text

Inflammation, Autoimmune Disease, Hepatology +10

FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinoma

Uğur Şahin, Ö. Türeci, Georgy M. Manikhas et al. · Annals of Oncology · 2021 · 338 citations · Full text

Gastrointestinal Oncology, Medicine, Gastro-oesophageal Adenocarcinoma +10

Predictors of functional decline in elderly patients undergoing transcatheter aortic valve implantation (TAVI)

Andreas W. Schoenenberger, Stefan Stortecky, Sandra Neumann et al. · European Heart Journal · 2012 · 291 citations · Full text

Aging, Elderly Patients, Geriatric Medicine +22

Clinical resistance to the kinase inhibitor PKC412 in acute myeloid leukemia by mutation of Asn-676 in the FLT3 tyrosine kinase domain

Florian H. Heidel, Fian K. Solem, Frank Breitenbuecher et al. · Blood · 2005 · 265 citations

A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study

Ö. Türeci, Uğur Şahin, Henning Schulze‐Bergkamen et al. · Annals of Oncology · 2019 · 232 citations · Full text